155 related articles for article (PubMed ID: 15509620)
1. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide.
Bechtold DA; Yue X; Evans RM; Davies M; Gregson NA; Smith KJ
Brain; 2005 Jan; 128(Pt 1):18-28. PubMed ID: 15509620
[TBL] [Abstract][Full Text] [Related]
2. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
Taylor JM; Pollard JD
Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
[TBL] [Abstract][Full Text] [Related]
3. Time Course of Axon and Myelin Degeneration in Peripheral Nerves in Experimental Autoimmune Neuritis Rats.
Tomikawa E; Mutsuga M; Hara K; Kaneko C; Togashi Y; Miyamoto Y
Toxicol Pathol; 2019 Jun; 47(4):542-552. PubMed ID: 30987532
[TBL] [Abstract][Full Text] [Related]
4. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Morsali D; Bechtold D; Lee W; Chauhdry S; Palchaudhuri U; Hassoon P; Snell DM; Malpass K; Piers T; Pocock J; Roach A; Smith KJ
Brain; 2013 Apr; 136(Pt 4):1067-82. PubMed ID: 23518709
[TBL] [Abstract][Full Text] [Related]
5. Axonal protection using flecainide in experimental autoimmune encephalomyelitis.
Bechtold DA; Kapoor R; Smith KJ
Ann Neurol; 2004 May; 55(5):607-16. PubMed ID: 15122700
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
[TBL] [Abstract][Full Text] [Related]
7. Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection.
Ambrosius B; Pitarokoili K; Schrewe L; Pedreiturria X; Motte J; Gold R
J Neuroinflammation; 2017 Apr; 14(1):92. PubMed ID: 28446186
[TBL] [Abstract][Full Text] [Related]
8. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
9. A Brain-Derived Neurotrophic Factor-Based p75
Gonsalvez DG; Tran G; Fletcher JL; Hughes RA; Hodgkinson S; Wood RJ; Yoo SW; De Silva M; Agnes WW; McLean C; Kennedy P; Kilpatrick TJ; Murray SS; Xiao J
eNeuro; 2017; 4(3):. PubMed ID: 28680965
[TBL] [Abstract][Full Text] [Related]
10. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats.
Izumo S; Linington C; Wekerle H; Meyermann R
Lab Invest; 1985 Aug; 53(2):209-18. PubMed ID: 2410663
[TBL] [Abstract][Full Text] [Related]
11. FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.
Kremer L; Taleb O; Boehm N; Mensah-Nyagan AG; Trifilieff E; de Seze J; Brun S
J Neuroinflammation; 2019 Mar; 16(1):54. PubMed ID: 30825874
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of leukemia inhibitory factor in experimental autoimmune neuritis.
Laurà M; Gregson NA; Curmi Y; Hughes RA
J Neuroimmunol; 2002 Dec; 133(1-2):56-9. PubMed ID: 12446008
[TBL] [Abstract][Full Text] [Related]
13. Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens.
Zhu W; Zhang K; Mix E; Wang X; Adem A; Zhu J
J Neurosci Res; 2011 Mar; 89(3):448-56. PubMed ID: 21259331
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Zhu J
J Neuroimmunol; 2003 Jul; 140(1-2):97-101. PubMed ID: 12864976
[TBL] [Abstract][Full Text] [Related]
15. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy.
Moalem-Taylor G; Allbutt HN; Iordanova MD; Tracey DJ
Brain Behav Immun; 2007 Jul; 21(5):699-710. PubMed ID: 17005365
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor in experimental autoimmune neuritis.
Felts PA; Smith KJ; Gregson NA; Hughes RA
J Neuroimmunol; 2002 Mar; 124(1-2):62-9. PubMed ID: 11958823
[TBL] [Abstract][Full Text] [Related]
18. Selective elimination of macrophages by dichlormethylene diphosphonate-containing liposomes suppresses experimental autoimmune neuritis.
Jung S; Huitinga I; Schmidt B; Zielasek J; Dijkstra CD; Toyka KV; Hartung HP
J Neurol Sci; 1993 Nov; 119(2):195-202. PubMed ID: 8277335
[TBL] [Abstract][Full Text] [Related]
19. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
[TBL] [Abstract][Full Text] [Related]
20. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.
Kapoor R; Davies M; Blaker PA; Hall SM; Smith KJ
Ann Neurol; 2003 Feb; 53(2):174-80. PubMed ID: 12557283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
